Kyndryl (NYSE:KD) vs. Aspyra (OTCMKTS:APYI) Head-To-Head Review

Aspyra (OTCMKTS:APYIGet Free Report) and Kyndryl (NYSE:KDGet Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, risk, valuation, institutional ownership, earnings, analyst recommendations and profitability.

Institutional and Insider Ownership

71.5% of Kyndryl shares are owned by institutional investors. 23.9% of Aspyra shares are owned by company insiders. Comparatively, 1.0% of Kyndryl shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Aspyra and Kyndryl, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aspyra 0 0 0 0 0.00
Kyndryl 0 0 4 0 3.00

Kyndryl has a consensus target price of $36.75, indicating a potential downside of 3.08%. Given Kyndryl’s stronger consensus rating and higher probable upside, analysts clearly believe Kyndryl is more favorable than Aspyra.

Profitability

This table compares Aspyra and Kyndryl’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Aspyra N/A N/A N/A
Kyndryl -0.58% -4.09% -0.46%

Earnings and Valuation

This table compares Aspyra and Kyndryl”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Aspyra N/A N/A N/A N/A N/A
Kyndryl $16.05 billion 0.55 -$340.00 million ($0.39) -97.22

Aspyra has higher earnings, but lower revenue than Kyndryl.

Risk & Volatility

Aspyra has a beta of 1.85, meaning that its share price is 85% more volatile than the S&P 500. Comparatively, Kyndryl has a beta of 1.86, meaning that its share price is 86% more volatile than the S&P 500.

Summary

Kyndryl beats Aspyra on 6 of the 10 factors compared between the two stocks.

About Aspyra

(Get Free Report)

Aspyra Inc. provides health care products and services for the laboratory and imaging marketplaces. It offers engineered workflow solutions that include software, interfaces, hardware, and professional services to various markets comprising specialty labs, reference labs, clinics, hospitals, imaging centers, and orthopedic practices. The company was formerly known as Creative Computer Applications Inc. and changed its name to Aspyra Inc. in November 2005. Aspyra Inc. was founded in 1978 and is headquartered in Jacksonville, Florida.

About Kyndryl

(Get Free Report)

Kyndryl Holdings, Inc. operates as a technology services company and IT infrastructure services provider worldwide. The company offers cloud services; core enterprise and zCloud services; application, data, and artificial intelligence services; digital workplace services; security and resiliency services; and network services and edge services. It serves financial, communications, retail and travel, and automotive industries. The company was incorporated in 2020 and is headquartered in New York, New York.

Receive News & Ratings for Aspyra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspyra and related companies with MarketBeat.com's FREE daily email newsletter.